Global Patent Index - EP 2490028 A4

EP 2490028 A4 20130710 - METHOD AND MARKER FOR DETERMINATION OF DEGREE OF RISK OF ONSET OF HIGH-FUNCTIONING AUTISM

Title (en)

METHOD AND MARKER FOR DETERMINATION OF DEGREE OF RISK OF ONSET OF HIGH-FUNCTIONING AUTISM

Title (de)

VERFAHREN UND MARKER ZUR BESTIMMUNG DES RISIKOGRADES FÜR DEN AUSBRUCH VON HIGH-FUNCTIONING-AUTISMUS

Title (fr)

PROCÉDÉ ET MARQUEUR POUR LA DÉTERMINATION DU DEGRÉ DE RISQUE D'APPARITION D'UN AUTISME DE HAUT NIVEAU

Publication

EP 2490028 A4 20130710 (EN)

Application

EP 10823205 A 20101014

Priority

  • JP 2009236976 A 20091014
  • JP 2010006114 W 20101014

Abstract (en)

[origin: EP2490028A1] It is an object of the present invention to provide an objective and simple method for determining the degree of risk of onset of autism, using a biological marker, and to enable to provide an appropriate treatment to the autistic patient at an early stage by finding an autistic patient at an early stage using the aforementioned method. The present invention relates to a method for determining the degree of risk of onset of autism, comprising the step of measuring the triglyceride concentration or the cholesterol concentration in a very low-density lipoprotein fraction of plasma or serum isolated from a subject, or the triglyceride concentration or the cholesterol concentration of plasma or serum. In addition, the present invention provides a kit for determining the degree of risk of onset of autism and a method for screening for a candidate substance for agents for treating autism using a non-human mammal, in which the above described method is utilized.

IPC 8 full level

G01N 33/92 (2006.01); C12Q 1/26 (2006.01); C12Q 1/44 (2006.01); C12Q 1/48 (2006.01); G01N 33/15 (2006.01); G01N 33/50 (2006.01)

CPC (source: EP US)

C12Q 1/60 (2013.01 - EP US); G01N 33/92 (2013.01 - EP US); G01N 2800/28 (2013.01 - EP US)

Citation (search report)

  • [Y] WO 2009012595 A1 20090129 - PHENOMENOME DISCOVERIES INC [CA], et al
  • [XI] MATSUZAKI H ET AL: "Dyslipidemia in male patients with high-functioning autism", SOCIETY FOR NEUROSCIENCE ABSTRACT VIEWER AND ITINERARY PLANNER, vol. 39, 22 September 2009 (2009-09-22), & 39TH ANNUAL MEETING OF THE SOCIETY-FOR-NEUROSCIENCE; CHICAGO, IL, USA; OCTOBER 17 -21, 2009, XP002697886
  • [Y] SIKORA DARRYN M ET AL: "The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome", AMERICAN JOURNAL OF MEDICAL GENETICS, vol. 140A, no. 14, July 2006 (2006-07-01), pages 1511 - 1518, XP002697887
  • [A] KIM E K ET AL: "Dyslipidemia in children with autism", REPRODUCTIVE TOXICOLOGY, ELSEVIER SCIENCE, US, vol. 28, no. 2, 1 September 2009 (2009-09-01), pages 136, XP026348418, ISSN: 0890-6238, [retrieved on 20090721]
  • See references of WO 2011045937A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

EP 2490028 A1 20120822; EP 2490028 A4 20130710; EP 2490028 B1 20161130; CN 102597781 A 20120718; CN 102597781 B 20140903; JP 5757627 B2 20150729; JP WO2011045937 A1 20130304; US 2012231484 A1 20120913; US 8518659 B2 20130827; WO 2011045937 A1 20110421

DOCDB simple family (application)

EP 10823205 A 20101014; CN 201080046519 A 20101014; JP 2010006114 W 20101014; JP 2011536046 A 20101014; US 201013501147 A 20101014